Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Deloitte
Dow
Queensland Health
UBS
Teva
QuintilesIMS
Baxter
Merck

Generated: January 23, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,342,482

« Back to Dashboard

Which drugs does patent 6,342,482 protect, and when does it expire?

Patent 6,342,482 protects NATROBA and is included in one NDA.

This patent has thirty-seven patent family members in twenty-eight countries.

Summary for Patent: 6,342,482
Title: Formulations for controlling human lice
Abstract:Safer pediculicidal formulations comprising a spinosyn, or a physiologically acceptable derivative or salt thereof, and a physiologically acceptable carrier, and methods of controlling lice infestations in a human with these formulations are provided.
Inventor(s): Snyder; Daniel Earl (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:09/543,441
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 6,342,482

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Parapro Llc NATROBA spinosad SUSPENSION;TOPICAL 022408-001 Jan 18, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,342,482

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 326212 ➤ Try a Free Trial
Australia 4700499 ➤ Try a Free Trial
Australia 750046 ➤ Try a Free Trial
Brazil 9911795 ➤ Try a Free Trial
Canada 2337789 ➤ Try a Free Trial
China 1129430 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
Cantor Fitzgerald
Deloitte
Cipla
Fuji
Teva
US Department of Justice
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.